The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 45 | — | 20.1x | Near average | |
Growth | 64 | 65.0% | 5.6% | Near average | |
Quality | 65 | 78.3% | 7.6% | Near average | |
Safety | 42 | 5.5x | 0.4x | Near average | |
Capital Return | 89 | — | 2.19% | Above average | |
Momentum | 78 | — | — | Above average | |
Sentiment | 31 | — | — | Below average |
Fennec Pharmaceuticals Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Fennec Pharmaceuticals Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
FENC stock saw a decline in the average target price from 18 to 17 dollars over the last 30 days, a decrease of 5.56%. This change is primarily due to one analyst exiting coverage (the count decreased from 3 to 2), which led to a narrowing of the dispersion range among analysts to between 16 and 18 dollars. Despite this technical adjustment in the average, recent qualitative ratings from institutions such as B. Riley and Piper Sandler remain positive (Buy/Overweight), indicating continued confidence in the stock's intrinsic value.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.